Global Pharmaceutical Industry Export Market Share by Country

In 2024, Germany leads the global pharmaceutical export market with a 14.2% share, followed by Ireland at 10.59% and the United States at 8.84%. France, the United Kingdom, and the Netherlands each hold between 4% and 5%, indicating a strong presence in Europe. Other notable countries include Sweden, Slovenia, and Singapore, with smaller shares of around 1-2%. Countries like South Korea, Poland, and Greece have less than 1% market share, indicating relatively minor roles in this market.

Over the last two years, there has been minimal variation in market shares, with most countries maintaining stable positions. The Compound Annual Growth Rate (CAGR) shows steady growth for countries with significant shares, while smaller players have seen minor fluctuations.

Future trends to watch for include emerging markets gaining traction due to increased investments in pharmaceutical technologies and production capacities. Additionally, shifts in global trade policies and health crises could influence export dynamics, potentially redistributing market shares among both established and emerging players.